Skip to main content

Table 1 Clinical characteristics of the patients included in the study

From: Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis

  DCF, N = 37 bDCF, N = 22 p value
Age (years)a 61.2 ± 9.5 67.1 ± 7.3 0.016
Sex    0.725
 Male/female 30/7 17/5  
Tumor locationb    0.045
 Ut/Mt./Lt/Ae 5/21/10/1 2/10/4/6  
Clinical T stagec    0.502
 T1/T2/T3/T4a/T4b 1/3/14/8/11 1/0/6/5/10  
Clinical N stagec    0.625
 N0/N1/N2/N3 2/29/5/1 2/15/5/0  
Clinical M stagec    0.599
 M0/M1 (LYM) 34/4 21/1  
Clinical stagec    0.151
 IIA/IIB/IIIA/IIIB/IIIC/IV 1/3/20/2/8/3 1/0/7/1/12/1  
ASAPS    0.082
 1/2/3 13/21/3 2/18/2  
Comorbidities
 Heart disease 8 15 < 0.001
 Pulmonary disease 1 4 0.039
 Diabetes mellitus 5 5 0.362
  1. Ae abdominal esophagus, ASAPS American Society of Anesthesiologists performance states, Lt lower thoracic esophagus, LYM lymph node metastasis, Mt. middle thoracic esophagus, Ut upper thoracic esophagus
  2. aMean ± standard deviation
  3. bAccording to the Japanese Classification of Esophageal Cancer, 11th edition
  4. cAccording to the UICC classification, 7th edition